Understanding how Alzheimer's disease progresses using brain imaging
Mapping Trajectories of Alzheimer's Progression via Personalized Brain Anchor-nodes
This study is looking at how Alzheimer's disease changes the brain over time, using special imaging techniques to create personalized maps that show both typical patterns and unique differences in brain structure, helping to better understand the stages of the disease for each person.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-11020978 on NIH RePORTER |
What this research studies
This research investigates the progression of Alzheimer's disease (AD) by identifying specific brain landmarks that can help in understanding how the disease develops over time. By utilizing advanced magnetic resonance imaging (MRI) techniques and deep learning methods, the study aims to create personalized models that reflect both common patterns and individual variations in brain structure and connectivity. This approach will help in mapping the stages of Alzheimer's, from early signs to advanced dementia, providing a clearer picture of the disease's trajectory for each patient.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at various stages of Alzheimer's disease, from asymptomatic to those with mild symptoms.
Not a fit: Patients with other forms of dementia or neurological disorders unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate early diagnosis and personalized treatment plans for individuals with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using MRI biomarkers for Alzheimer's, but this approach of personalized brain anchor-nodes is relatively novel.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Zhu, Dajiang — University of Texas Arlington
- Study coordinator: Zhu, Dajiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.